Singapore markets closed

Aptose Biosciences Inc. (APTO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.1800-0.0100 (-0.84%)
At close: 04:00PM EDT
1.1900 +0.01 (+0.85%)
After hours: 07:54PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-47,171
-51,207
-41,823
-65,354
-55,238
Depreciation & amortisation
444
466
528
622
614
Stock-based compensation
2,588
3,653
5,207
12,949
21,438
Change in working capital
-621
2,810
4,317
1,516
-262
Accounts payable
-3,098
-280
7,611
-472
211
Other working capital
-45,080
-44,619
-32,346
-43,516
-33,970
Other non-cash items
-304
-312
-571
6,970
-435
Net cash provided by operating activities
-45,051
-44,590
-32,322
-43,304
-33,891
Cash flows from investing activities
Investments in property, plant and equipment
-
-29
-24
-212
-79
Purchases of investments
-
-
-
-34,996
-
Sales/maturities of investments
-
-
-
-
12,707
Net cash used for investing activities
10,929
9,960
30,066
-35,208
12,628
Cash flows from financing activities
Common stock issued
18,676
6,881
101
36
58,402
Other financing activities
-
-
-
-
-168
Net cash used provided by (used for) financing activities
18,707
6,910
116
226
58,807
Net change in cash
-15,416
-27,718
-2,144
-78,279
37,551
Cash at beginning of period
22,762
36,970
39,114
117,393
79,842
Cash at end of period
7,347
9,252
36,970
39,114
117,393
Free cash flow
Operating cash flow
-45,051
-44,590
-32,322
-43,304
-33,891
Capital expenditure
-
-29
-24
-212
-79
Free cash flow
-45,080
-44,619
-32,346
-43,516
-33,970